Celeste Bello
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 30
-
- Lymphoma Diagnosis and Treatment 50
- Hematology top 5%
- Acute Myeloid Leukemia Research 7
- Oncology top 5%
- Viral-associated cancers and disorders 12
- CAR-T cell therapy research 5
- Immunology top 10%
-
- CNS Lymphoma Diagnosis and Treatment 17
-
- Acute Lymphoblastic Leukemia research 8
-
- Lung Cancer Treatments and Mutations 8
- Co-authors
- Eduardo M. SotomayorLubomir SokolBrad S. KahlBrian J. LannuttiJohn C. ByrdDon M. BensonRoger G. UlrichHeather K. Webb
- Partner nations
- United StatesBelgiumItaly
In The Last Decade
Celeste Bello
51 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 63
- Genetics 640
- Pathology and Forensic Medicine 808
- Hematology 250
- Oncology 544
- Immunology 247
Countries citing papers authored by Celeste Bello
This map shows the geographic impact of Celeste Bello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Celeste Bello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Celeste Bello more than expected).
Fields of papers citing papers by Celeste Bello
This network shows the impact of papers produced by Celeste Bello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Celeste Bello. The network helps show where Celeste Bello may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Celeste Bello, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 0 | |
| 7 | 2020 | 4 | |
| 8 | 2019 | 3 | |
| 9 | 2019 | 3 | |
| 10 | 2019 | 0 | |
| 11 | 2016 | 12 | |
| 12 | 2014 | 55 | |
| 13 | 2014 | 12 | |
| 14 | 2014 | 1 | |
| 15 | 2013 | 2 | |
| 16 | 2013 | 11 | |
| 17 | 2011 | 40 | |
| 18 | 2011 | 5 | |
| 19 | 2008 | 10 | |
| 20 | 2007 | 76 |
About Celeste Bello
Celeste Bello is a scholar working on Genetics, Pathology and Forensic Medicine, Neurology, Oncology and Hematology, having authored 63 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (50 papers), Chronic Lymphocytic Leukemia Research (30 papers), CNS Lymphoma Diagnosis and Treatment (17 papers), Viral-associated cancers and disorders (12 papers), Acute Lymphoblastic Leukemia research (8 papers), Lung Cancer Treatments and Mutations (8 papers), Acute Myeloid Leukemia Research (7 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Genetics (640 citations), Pathology and Forensic Medicine (808 citations), Hematology (250 citations), Oncology (544 citations) and Immunology (247 citations). Celeste Bello has collaborated with scholars based in United States, Belgium and Italy. Frequent co-authors include Eduardo M. Sotomayor, Lubomir Sokol, Brad S. Kahl, Brian J. Lannutti, John C. Byrd, Don M. Benson, Roger G. Ulrich, Heather K. Webb, Nina D. Wagner‐Johnston and Sissy Peterman. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia Research, Blood Advances and Cancer Control.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.